Global Heart Closure Devices Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Heart Closure Devices Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The market valuation for heart closure devices has experienced considerable expansion lately, projected to elevate from $2.77 billion in the year 2024 to reach $3.08 billion by 2025, reflecting an aggregated annual growth rate (CAGR) of 11.2%. This upward trajectory observed during the past period is largely fueled by heightened cognizance among medical professionals, a rising number of regulatory endorsements for these devices, the implementation of more supportive reimbursement frameworks, a greater prevalence of cardiac ailments, and the expanding proportion of elderly individuals within the populace.

Anticipation surrounds the heart closure devices sector, predicting substantial expansion over coming years, as the market valuation is projected to reach $4.86 billion by 2029, fueled by an annual compounded growth rate (CAGR) of 12.0%; this upward trajectory is fundamentally driven by the escalating prevalence of congenital heart abnormalities, the greater utilization of MRI examinations, a growing count of cardiac strokes, the rising occurrences of atrial fibrillation, alongside a marked preference for surgical interventions that involve less invasiveness, whereas key directional shifts anticipated within this timeframe encompass the incorporation of devices offering multiple functionalities, continuous technological evolution, advancements in material science and product blueprints, the assimilation of sophisticated imaging systems, and pioneering efforts in developing materials that can be naturally reabsorbed by the body.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20828&type=smp

What Are The Key Drivers Of Growth In The Heart Closure Devices Market?

Elevated rates of cardiovascular ailments are anticipated to fuel the expansion of the market for heart closure apparatuses moving ahead.This rise in cardiovascular disease occurrences is attributed to an aging populace, poor lifestyle habits, inherited vulnerabilities, and the growing ubiquity of risk elements like elevated blood pressure, diabetes, and excess weight.Heart closure technologies facilitate the management of complications arising from congenital heart anomalies by employing non-surgical techniques to seal aberrant openings within the heart, thereby enhancing circulation and averting subsequent health deterioration.To illustrate this trend, data from the Singapore Heart Foundation (SHF), a charitable entity headquartered in Singapore, indicated that cardiovascular diseases were responsible for 26,885 fatalities in the year 2023, with ischemic heart disease alone causing 5,302 deaths, a slight uptick from the 5,290 recorded in 2022; consequently, the escalating prevalence of CVDs directly necessitates greater use of heart closure devices, thereby stimulating market expansion.

What Are The Key Segments In The Heart Closure Devices Market?

The heart closure devicesmarket covered in this report is segmented –

1) By Product: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Left Atrial Appendage (LAA) Closure Devices, Other Products

2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials

3) By Mode of Delivery: Transcatheter Delivery, Surgical Delivery

4) By End Use: Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Catheterization Laboratories, Other End Uses

Subsegments:

1) By Atrial Septal Defect (ASD) Closure Devices: Self-expanding Occluders, Balloon-expandable Occluders, Other ASD Closure Devices

2) By Ventricular Septal Defect (VSD) Closure Devices: Transcatheter VSD Closure Devices, Surgical VSD Closure Devices, Other VSD Closure Devices

3) By Patent Foramen Ovale (PFO) Closure Devices: Double-Disc Occluders, Single-Disc Occluders, Other PFO Closure Devices

4) By Left Atrial Appendage (LAA) Closure Devices: LAA Occluders, LAA Clip Systems, Other LAA Closure Devices

5) By Other Products: Septal Defect Closure Devices, Endovascular Closure Devices, Other Specialty Closure Devices

What Are The Major Trends Driving The Growth Of The Heart Closure Devices Market?

Leading firms within the cardiac closure device sector are concentrating their efforts on engineering sophisticated technological offerings, exemplified by patent foramen ovale occlusion technologies, with the dual aims of enhancing the results for patients and minimizing issues during medical procedures. Patent foramen ovale (PFO) closure mechanisms represent specialized hardware employed to seal a persistent aperture in the cardiac structure, specifically the PFO, which is an interatrial communication that customarily seals shortly after delivery but persists open. As an illustration, in the month of September in 2022, Abbott Laboratories, a corporation situated in the United States that specializes in medical apparatus, introduced the Amplatzer Talisman PFO Occlusion System to the market. This cutting-edge apparatus has been engineered specifically to aid patients living with a PFO, especially those who have previously suffered a stroke and face an elevated likelihood of another episode. The system boasts several key attributes, including a pre-connected occluder to simplify the intervention process, a flexible 30mm dimension allowing for superior accommodation, and a design that permits complete retrieval, all contributing to the effective closure of the PFO and consequently mitigating the probability of subsequent cerebrovascular incidents.

Who Are The Major Companies Operating In The Heart Closure Devices Market?

Major companies operating in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., MicroPort Scientific Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/heart-closure-devices-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Heart Closure Devices Market?

North America was the largest region in the heart closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart closure devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Heart Closure Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20828&type=smp

Browse Through More Reports Similar to the Global Heart Closure Devices Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Flea Tick And Heartworm Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flea-tick-and-heartworm-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795